| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |